Analyst calls of the week: NVIDIA, DocGo, TerrAscend, Newmont Gold and more

We saw our previous prediction of municipal contracts helping cushion DocGo's revenue (absent of the Covid test) work out for its full year of 2022. The technological advantage in operations and low debt burden combined with ample liquidity put the company on a strong footing for future growth.

DocGo: Strong Showing Overall With Potential Fast Topline Growth

DocGo Inc, a last-mile health services company, continues to prove it can successfully replace its COVID testing revenue after it posted 4Q results that beat expectations, according to analysts at Canaccord Genuity (TSX:CF, LSE:CF). In a note to clients, the analysts highlighted that DocGo's results beat both their and the consensus estimates for the quarter.

DocGo earns repeat ‘Buy' rating from Canaccord on proven ability to replace COVID testing revenue

DocGo Inc (NASDAQ: DCGO) has emerged as a buyable growth stock for 2023, which is saying something. The fallout from SVB's collapse is yet to be felt and will impact growth names this year.

DocGo: A Growth Stock Going Higher In 2023

Start Time: 17:00 January 1, 0000 5:41 PM ET DocGo Inc. (NASDAQ:DCGO ) Q4 2022 Earnings Conference Call March 13, 2023, 17:00 PM ET Company Participants Anthony Capone - CEO Norman Rosenberg - CFO Lee Bienstock - President and COO Mike Cole - Vice President, IR Conference Call Participants Richard Close - Canaccord Genuity Ryan MacDonald - Needham & Company David Grossman - Stifel Kieran Ryan - Deutsche Bank Operator Greetings, and welcome to the DocGo Fourth Quarter and Full Year 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.

DocGo Inc. (DCGO) Q4 2022 Earnings Call Transcript

DocGo Inc. (DCGO) delivered earnings and revenue surprises of 120% and 4.47%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

DocGo Inc. (DCGO) Tops Q4 Earnings and Revenue Estimates

DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.